Presidio Property Trust Azioni (NASDAQ: SQFT)

Ultime notizie per Presidio Property Trust (NASDAQ:SQFT) Azioni

Presidio Property Trust

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

Presidio Property Trust, Inc. - Class A Common Stock

Presidio Property Trust Inc

Presidio Property Trust, Inc. - 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share

Presidio Property Trust, Inc. - Series A Common Stock Purchase Warrants

Dropbox (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBX#NASDAQ">DBX</a>) raises FY2025 sales outlook from $2.46 billion-$2.48 billion to $2.48 billion-$2.49 billion vs $2.48 billion estimate.

News

Guidance

Dropbox Raises FY2025 Sales Guidance from $2.46B-$2.48B to $2.48B-$2.49B vs $2.48B Est

Howmet Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) has outperformed the market over the past 5 years by 55.38% on an annualized basis producing an average annual return of 69.92%. Currently, Howmet Aerospace has a market capitalization of $64.21 billion. 
Buying $1000 In HWM: If an investor had bought $1000 of HWM stock 5 years ago, it would be worth $13,392.86 today based on a price of $159.06 for HWM at the time of writing.
<h3>Howmet Aerospace's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746742516_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $1000 Invested In Howmet Aerospace 5 Years Ago Would Be Worth Today

Dropbox (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBX#NASDAQ">DBX</a>) sees Q2 sales of $616.000 million-$619.000 million vs $617.83 million analyst estimate.

Dropbox Sees Q2 Sales $616.000M-$619.000M vs $617.83M Est

Globalstar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSAT#NASDAQ">GSAT</a>) affirms FY2025 sales outlook from $260.00 million-$285.00 million to $260.00 million-$285.00 million.

GSAT

Globalstar Affirms FY2025 Sales Guidance of $260.00M-$285.00M

Globalstar (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GSAT#AMEX">GSAT</a>) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.02) by 700 percent. This is a 6.67 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $60.03 million which missed the analyst consensus estimate of $64.54 million by 6.99 percent. This is a 6.29 percent increase over sales of $56.48 million the same period last year.

Earnings

Earnings Misses

Globalstar Q1 EPS $(0.16) Misses $(0.02) Estimate, Sales $60.03M Miss $64.54M Estimate

Toast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) released its first-quarter results after Thursday's closing bell. Here's a look at the details <a href="https://www.benzinga.com/pressreleases/25/05/b45299394/toast-announces-first-quarter-2025-financial-results">in the report. </a>
The Details: Toast reported quarterly earnings of nine cents per share, which missed the Street estimate of 12 cents. Quarterly revenue came in at $1.34 billion, in line with the consensus estimate.
The company <a href="https://www.benzinga.com/pressreleases/25/05/b45299714/toast-tees-up-new-technology-platform-for-topgolf">also announced</a> an agreement with Topgolf to implement Toast Enterprise Solutions across its venues in the U.S.
Read Next: <a href="https://www.benzinga.com/news/earnings/25/05/45292652/thursdays-top-5-trending-stocks-whats-going-on-with-d-wave-novavax-carvana?utm_source=articleShare">Thursday&#8217;s Top 5 Trending Stocks: What&#8217;s Going On With D-Wave, Novavax, Carvana?</a>
For the first quarter, Toast reported: 
<ul>
<li>ARR as of March 31, 2025, was $1.7 billion, up 31% year-over-year.</li>
<li>Total Locations increased 25% year-over-year to approximately 140,000.</li>
<li>Gross Payment Volume (GPV) increased 22% year-over-year to $42.2 billion.</li>
<li>Non-GAAP subscription services and financial technology solutions gross profit grew 37% year-over-year to $415 million.</li>
</ul>
&#8220;Toast kicked off the year with a fantastic first quarter — we added over 6,000 net new locations, grew our recurring gross profit streams 37%, and delivered $133 million in Adjusted EBITDA,&#8221; said Toast CEO Aman Narang.
&#8220;We continue to see strong momentum across both our core business as well as our new verticals in international, retail, and enterprise including marquee wins in Applebee&#8217;s and Topgolf. We are starting to see our scale and data across our 140,000 locations help our customers be more successful, which sets us up well as we continue to build out the platform and scale globally,&#8221; Narang added. 
TOST Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Toast stock was up 8.43% at $39.74 after-hours Thursday.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/travel/25/05/45260938/disneys-new-abu-dhabi-theme-park-will-be-authentically-disney-and-distinctly-emirati-ceo-bob-iger-says?utm_source=articleShare">Disney&#8217;s New Abu Dhabi Theme Park Will Be &#8216;Authentically Disney And Distinctly Emirati,&#8217; CEO Bob Iger Says&nbsp;</a></li>
</ul>
Photo: Shutterstock

Restaurants

After-Hours Center

Movers

Tech

TOST

Toast Stock Rallies After Q1 Results, Signs Agreement With Topgolf

J.P. Morgan analyst Bill Peterson reiterated an Overweight rating on the shares of Evgo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGO#NASDAQ">EVGO</a>) with a price forecast of $5.00.
EVgo <a target="_blank" href="https://www.benzinga.com/25/05/45233228/whats-going-on-with-evgo-stock-today" rel="noreferrer noopener">beat revenue expectations</a>, thanks in part to stronger-than-anticipated performance from its eXtend business, said the analyst.
The company reaffirmed both its financial and stall deployment targets, easing investor concerns around the stability of its Department of Energy (DOE) loan, which saw a second drawdown in April and remains on track for quarterly disbursements over five years.
Management believes EVgo is well-positioned to grow market share in fast charging, especially as peers face challenges from uncertain EV policies and reduced spending by site hosts.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/05/45236630/ford-outperforms-in-q1-faces-tariff-challenges-ahead-say-analysts" rel="noreferrer noopener">Ford Outperforms In Q1, Faces Tariff Challenges Ahead, Say Analysts</a>
The analyst stated that additional non-dilutive funding and potential small-scale acquisitions may further support growth.
Tariff-related cost impacts are expected to be manageable at around $4–5 million in 2025, with much of the affected equipment already in inventory or en route. The company anticipates that cost-saving measures will help absorb these expenses.
EVgo operates one of the largest DC fast-charging networks in the U.S., generating revenue from its expanding charger base.
The company adds capacity based on growing demand and offers a reliable network that is compatible with all EVs, including Teslas, without adapters.
With strong partnerships across automakers, rideshare, and autonomous fleets, EVgo is well-positioned for robust revenue growth, driven by rising utilization, faster charging, and potential DOE loan support, concluded the analyst.
Price Action: EVGO shares closed higher by 4.36% at $3.83 on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/45299775" target="_blank" rel="noreferrer noopener">Tesla Tried To Trademark &#8216;Robotaxi&#8217; And &#8216;Cybercab&#8217; Terms: Why It Could Be Forced To Pick A New Name</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Price Target

Reiteration

Analyst Ratings

General

EVGO

TSLA

EVgo Is Well-Positioned For Robust Revenue Growth: Analyst

ECN Capital (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ECN#TSX">ECN</a>) reported quarterly earnings of $0.03 per share. The company reported $56.63 million in sales this quarter. This is a 14.16 percent increase over sales of $49.61 million the same period last year.

TSX:ECN

ECN Capital Q1 Adj. EPS $0.03, Sales $56.63M Up From $49.61M YoY

Alliant Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNT#NASDAQ">LNT</a>) affirms FY2025 Adj EPS guidance from $3.15-$3.25 to $3.15-$3.25 vs $3.21 analyst estimate..

Alliant Energy Affirms FY2025 Adj EPS Guidance of $3.15-$3.25 vs $3.21 Est

Alliant Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNT#NASDAQ">LNT</a>) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.66 by 25.76 percent. This is a 33.87 percent increase over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of $1.13 billion which beat the analyst consensus estimate of $985.38 million by 14.47 percent. This is a 9.41 percent increase over sales of $1.03 billion the same period last year.

Earnings Beats

Alliant Energy Q1 Adj. EPS $0.83 Beats $0.66 Estimate, Sales $1.13B Beat $985.38M Estimate

Alaris Equity Partners (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AD#TSX">AD</a>) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.40 by 25 percent. This is a 67.11 percent decrease over earnings of $1.52 per share from the same period last year. The company reported quarterly sales of $36.39 million which missed the analyst consensus estimate of $43.82 million by 16.96 percent. This is a 23.28 percent decrease over sales of $47.43 million the same period last year.

TSX:AD

Alaris Equity Partners Q1 EPS $0.50 Beats $0.40 Estimate, Sales $36.39M Miss $43.82M Estimate

Atlanticus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATLC#NASDAQ">ATLC</a>) reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.48 by 0.68 percent. This is a 36.7 percent increase over earnings of $1.09 per share from the same period last year. The company reported quarterly sales of $344.87 million which missed the analyst consensus estimate of $347.24 million by 0.68 percent. This is a 18.63 percent increase over sales of $290.71 million the same period last year.

ATLC

Atlanticus Holdings Q1 EPS $1.49 Beats $1.48 Estimate, Sales $344.87M Miss $347.24M Estimate

Turnstone Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSBX#NASDAQ">TSBX</a>) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.26) by 96.15 percent. This is a 40 percent increase over losses of $(0.85) per share from the same period last year.

TSBX

Turnstone Biologics Q1 EPS $(0.51) Misses $(0.26) Estimate

Doman Building Materials (TSX:<a class="ticker" href="https://www.benzinga.com/stock/DBM#TSX">DBM</a>) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.12 by 125 percent. This is a 68.75 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $793.20 million which beat the analyst consensus estimate of $757.38 million by 4.73 percent. This is a 31.66 percent increase over sales of $602.48 million the same period last year.

TSX:DBM

Doman Building Materials Q1 Adj. EPS $0.27 Beats $0.12 Estimate, Sales $793.20M Beat $757.38M Estimate

NNBR

CORRECTION: NN Lowers FY2025 Sales Guidance To $430.00M-$460.00M vs $454.30M Est

Ziff Davis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZD#NASDAQ">ZD</a>) affirms FY2025 Adj EPS guidance from $6.64-$7.28 to $6.64-$7.28 vs $6.97 analyst estimate. Affirms FY2025 sales outlook from $1.44 billion-$1.50 billion to $1.44 billion-$1.50 billion vs $1.46 billion estimate.

Ziff Davis Affirms FY2025 Adj EPS Guidance of $6.64-$7.28 vs $6.97 Est; Affirms FY2025 Sales Guidance of $1.44B-$1.50B vs $1.46B Est

Karat Packaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRT#NASDAQ">KRT</a>) affirms FY2025 sales outlook from $460.67 million-$469.12 million to $460.67 million-$469.12 million vs $461.42 million estimate.

Karat Packaging Reiterating FY2025 guidance on net sales, gross margin and adjusted EBITDA margin.

Ziff Davis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZD#NASDAQ">ZD</a>) reported quarterly earnings of $1.14 per share which missed the analyst consensus estimate of $1.25 by 8.8 percent. This is a 10.24 percent decrease over earnings of $1.27 per share from the same period last year. The company reported quarterly sales of $328.64 million which beat the analyst consensus estimate of $324.19 million by 1.37 percent. This is a 4.50 percent increase over sales of $314.49 million the same period last year.

Ziff Davis Q1 Adj. EPS $1.14 Misses $1.25 Estimate, Sales $328.64M Beat $324.19M Estimate

Canacol Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CNE#TSX">CNE</a>) reported quarterly earnings of $0.93 per share. This is a 745.45 percent increase over earnings of $0.11 per share from the same period last year. The company reported $72.73 million in sales this quarter. This is a 6.38 percent decrease over sales of $77.69 million the same period last year.

TSX:CNE

Canacol Energy Q1 EPS $0.93 Up From $0.11 YoY, Sales $72.73M Down From $77.69M YoY

Across the recent three months, 4 analysts have shared their insights on Generation Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBIO#NASDAQ">GBIO</a>), expressing a variety of opinions spanning from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $8.25, with a high estimate of $9.00 and a low estimate of $8.00. Holding firm without variation, the current average remains at the previous average price target. 
<img src="https://www.benzinga.com/files/images/story/2025/1746741664_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of Generation Bio by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gil Blum</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Gil Blum</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Whitney Ijem</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$9.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Gil Blum</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Generation Bio. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Generation Bio compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Generation Bio's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Generation Bio's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/GBIO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Generation Bio analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About Generation Bio</h2>
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
<h3>Unraveling the Financial Story of Generation Bio</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Generation Bio's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 45.52% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Generation Bio's net margin excels beyond industry benchmarks, reaching -510.55%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Generation Bio's ROE excels beyond industry benchmarks, reaching -22.43%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Generation Bio's ROA excels beyond industry benchmarks, reaching -8.91%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 1.09, Generation Bio adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GBIO

Where Generation Bio Stands With Analysts

Press Releases

Presidio Property Trust Announces Update of Share Repurchase Program

Dividends

Presidio Property Trust Announces Series D Preferred Stock Cash Dividend

Presidio Property Trust Provides Update on Model Home Activity in Q4 2024

Presidio Property Trust Announces Sales of Union Town Center and Research Parkway Properties

Presidio Property Trust Provides Update on Real Estate Activity in January and February 2025

Real Estate

Presidio Property Trust, Inc. Announces Earnings for the Year Ended December 31, 2024

CORRECTION – Presidio Property Trust, Inc. Announces Earnings for the Year Ended December 31, 2024

Presidio Property Trust Commences a Tender Offer to Repurchase up to 2,000,000 shares, plus all odd lots, of its Series A Common Stock

Presidio Property Trust, Inc. Announces Final Results of Its Self Tender Offer for Shares of Class A Common Stock

SQFT

SQFTP

SQFTW

American Assets Trust

Armada Hoffler Properties, Inc. Common Stock

Armada Hoffler Properties

Alexander & Baldwin, Inc. Common Stock REIT Holding Company

Alexander & Baldwin

Broadstone Net Lease

CTO Realty Growth

Essential Properties Realty Trust, Inc. Common Stock

Essential Properties

Empire State Realty OP, L.P. Series ES Operating Partnership Units Representing Limited Partnership Interests

Empire State Realty OP

Empire State Realty OP, L.P. Series 250 Operating Partnership Units Representing Limited Partnership Interests

Generation Income Properties Inc. - Common stock

Generation Income

Global Net Lease

Gladstone Commercial Corporation - Real Estate Investment Trust

Gladstone Commercial

Medalist Diversified REIT, Inc. - Common Stock

Medalist Diversified REIT

Modiv Industrial, Inc. Class C Common Stock

Modiv Industrial

MacKenzie Realty Capital, Inc. - Common Stock

Mackenzie Realty Capital

NexPoint Diversified Real Estate Trust Common Stock

NexPoint Diversified Real

Empire State Realty OP, L.P. Series 60 Operating Partnership Units Representing Limited Partnership Interests

Comments

Presidio Property Trust

Notizie

Ultime notizie per Presidio Property Trust (NASDAQ:SQFT) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO